Sponsor content
23 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 0.25 mg semaglutide 0.5 mg/mL solution for injection pre-filled pen with pre-assembled needle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 0.5 mg semaglutide 1.0 mg/mL solution for injection pre-filled pen with pre-assembled needle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 1 mg semaglutide 2.0 mg/mL solution for injection pre-filled pen with pre-assembled needle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 1.7 mg semaglutide 2.27 mg/mL solution for injection pre-filled pen with pre-assembled needle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEGOVY 2.4 mg semaglutide 3.2 mg/mL solution for injection pre-filled pen with pre-assembled needle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOGROYA somapacitan 10 mg (6.7 mg/mL) solution for injection prefilled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYBELSUS semaglutide 7 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYBELSUS semaglutide 3 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYBELSUS semaglutide 14 mg tablet blister pack.
-
Australian public assessment report (AusPar)Rybelsus (semaglutide) has been approved for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.